Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ – STARS Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc proposes to combine with Allergan Inc

Tuesday, 22 Apr 2014 07:30am EDT 

Valeant Pharmaceuticals International Inc:Submits merger proposal to Allergan Inc under which each Allergan share would be exchanged for $48.30 in cash and 0.83 shares of Valeant common stock, based on the fully diluted number of Allergan shares outstanding.Shareholders will be able to elect mix of cash and shares, subject to proration.Allergan shareholders will own 43 pct of combined company and thereby continue to participate in expected value creation of combined company.Pershing Square, Allergan's largest shareholder with a 9.7 pct stake in Allergan, has agreed to elect only stock consideration in transaction and intends to remain long-term shareholder of combined company. 

Company Quote

0.116 +1.64%
9:26am EDT